We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > anticancer

News List

A Review of the Anticancer Drugs Approved in China in 2019 PharmaSources/Yefenghong
February 06, 2020
A review of the 7 blockbuster innovative oncology drugs approved by the NMPA (National Medical Products Administration of China) in 2019.
Silica-based drug delivery could improve anticancer drugs europeanpharmaceuticalreview
August 19, 2019
Researchers have developed silica spheres to contain cancer therapeutics that melt at certain temperatures and have the potential to improve drug delivery.
The “miracle drug” metformin has no anticancer efficacy? PharmaSources/Yefenghong
August 07, 2019
Three studies at the ASCO Meeting revealed surprising results
Mundipharma acquires global rights for CellAct’s biliary tract cancer treatment CAP7.1 pharmaceutical-technology
August 16, 2017
The Mundipharma network of independent associated companies has purchased worldwide development, commercialisation and production rights to CAP7.1 from CellAct for more than $250m.